-
1
المؤلفون: Enrique de Alava, María Jesús Pareja, David Carcedo, Natalia Arrabal, José-Francisco García, Reyes Bernabé-Caro
المساهمون: Roche, Álava, Enrique de, Pareja, María Jesús, Carcedo, David, Bernabé Caro, Reyes
المصدر: Expert Review of Pharmacoeconomics & Outcomes Research. 22:1033-1042
مصطلحات موضوعية: Lung Neoplasms, molecular profiling, Cost-Benefit Analysis, Health Policy, High-Throughput Nucleotide Sequencing, Non-small cell lung cancer (NSCLC), General Medicine, Sequential single testing, oncogenic drivers, Hospitals, Oncogenic drivers, Molecular profiling, Carcinoma, Non-Small-Cell Lung, sequential single testing, Mutation, Next-generation sequencing, Humans, Cost-effectiveness, next-generation sequencing, Pharmacology (medical), cost-effectiveness
وصف الملف: application/pdf
-
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3مورد إلكتروني
مصطلحات الفهرس: Non-small cell lung cancer (NSCLC), Molecular profiling, Oncogenic drivers, Cost-effectiveness, Next-generation sequencing, Sequential single testing, dataset
URL:
http://hdl.handle.net/10261/331777 https://doi.org/10.6084/m9.figshare.19883215.v1
Álava, Enrique de; Pareja, María Jesús; Carcedo, David; Arrabal, Natalia; García, José Francisco; Bernabé Caro, Reyes. Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective. https://doi.org/10.1080/14737167.2022.2078310 . http://hdl.handle.net/10261/305165https://doi.org/10.6084/m9.figshare.19883215.v1
Sí -
4مورد إلكتروني
مصطلحات الفهرس: Non-small cell lung cancer (NSCLC), Cost-effectiveness, Molecular profiling, Next-generation sequencing, Oncogenic drivers, Sequential single testing, artículo
URL:
http://hdl.handle.net/10261/305165 https://api.elsevier.com/content/abstract/scopus_id/85131084830 https://doi.org/10.1080/14737167.2022.2078310
Publisher's versionhttps://doi.org/10.1080/14737167.2022.2078310
Sí